TY - JOUR AU - EC, S. AU - M, N. AU - HI, G. AU - Grieken, N. C. AU - F, L. PY - 2020 DA - 2020// TI - Gastric cancer JO - Lancet (London, England) VL - 396 ID - EC2020 ER - TY - JOUR AU - Zhao, Y. AU - Zhang, J. AU - Cheng, A. PY - 2020 DA - 2020// TI - Gastric cancer: genome damaged by bugs JO - Oncogene VL - 39 ID - Zhao2020 ER - TY - JOUR AU - Li, W. AU - Zhang, X. AU - Wu, F. PY - 2019 DA - 2019// TI - Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer JO - Cell Death Dis VL - 10 ID - Li2019 ER - TY - JOUR AU - Montagnani, F. AU - Crivelli, F. AU - Aprile, G. PY - 2018 DA - 2018// TI - Long-term survival after liver metastasectomy in gastric cancer: systematic review and meta-analysis of prognostic factors JO - Cancer Treat Rev VL - 69 ID - Montagnani2018 ER - TY - JOUR AU - Kitayama, J. AU - Ishigami, H. AU - Yamaguchi, H. PY - 2018 DA - 2018// TI - Treatment of patients with peritoneal metastases from gastric cancer JO - Ann Gastroenterol Surg VL - 2 ID - Kitayama2018 ER - TY - JOUR AU - Song, Y. AU - Wang, Y. AU - Tong, C. PY - 2017 DA - 2017// TI - A unified model of the hierarchical and stochastic theories of gastric cancer JO - Br J Cancer VL - 116 ID - Song2017 ER - TY - JOUR AU - Jakubek, M. AU - Kejik, Z. AU - Kaplanek, R. PY - 2019 DA - 2019// TI - Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer JO - Biomed Pharmacother VL - 118 ID - Jakubek2019 ER - TY - JOUR AU - Wu, Q. AU - Yang, Z. AU - Nie, Y. AU - Shi, Y. AU - Fan, D. PY - 2014 DA - 2014// TI - Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches JO - Cancer Lett VL - 347 ID - Wu2014 ER - TY - JOUR AU - Wang, J. H. AU - Du, J. P. AU - Zhang, Y. H. PY - 2011 DA - 2011// TI - Dynamic changes and surveillance function of prion protein expression in gastric cancer drug resistance JO - World J Gastroenterol VL - 17 ID - Wang2011 ER - TY - JOUR AU - Leist, M. AU - Jaattela, M. PY - 2001 DA - 2001// TI - Four deaths and a funeral: from caspases to alternative mechanisms JO - Nat Rev Mol Cell Biol VL - 2 ID - Leist2001 ER - TY - JOUR AU - Kaufmann, S. H. AU - Gores, G. J. PY - 2000 DA - 2000// TI - Apoptosis in cancer: cause and cure JO - BIOESSAYS VL - 22 ID - Kaufmann2000 ER - TY - JOUR AU - Johnstone, R. W. AU - Ruefli, A. A. AU - Lowe, S. W. PY - 2002 DA - 2002// TI - Apoptosis: a link between cancer genetics and chemotherapy JO - Cell VL - 108 ID - Johnstone2002 ER - TY - JOUR AU - Park, H. AU - Cho, S. Y. AU - Kim, H. PY - 2015 DA - 2015// TI - Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer JO - Proc Natl Acad Sci U S A VL - 112 ID - Park2015 ER - TY - JOUR AU - Youle, R. J. AU - Strasser, A. PY - 2008 DA - 2008// TI - The BCL-2 protein family: opposing activities that mediate cell death JO - Nat Rev Mol Cell Biol VL - 9 ID - Youle2008 ER - TY - JOUR AU - Adams, J. M. AU - Cory, S. PY - 2007 DA - 2007// TI - The Bcl-2 apoptotic switch in cancer development and therapy JO - ONCOGENE VL - 26 ID - Adams2007 ER - TY - JOUR AU - Belmar, J. AU - Fesik, S. W. PY - 2015 DA - 2015// TI - Small molecule mcl-1 inhibitors for the treatment of cancer JO - Pharmacol Ther VL - 145 ID - Belmar2015 ER - TY - JOUR AU - Chen, L. AU - Willis, S. N. AU - Wei, A. PY - 2005 DA - 2005// TI - Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function JO - Mol Cell VL - 17 ID - Chen2005 ER - TY - JOUR AU - Ashkenazi, A. AU - Fairbrother, W. J. AU - Leverson, J. D. AU - Souers, A. J. PY - 2017 DA - 2017// TI - From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors JO - Nat Rev Drug Discov VL - 16 ID - Ashkenazi2017 ER - TY - JOUR AU - Tse, C. AU - Shoemaker, A. R. AU - Adickes, J. PY - 2008 DA - 2008// TI - ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor JO - Cancer Res VL - 68 ID - Tse2008 ER - TY - JOUR AU - Zhao, Y. AU - He, J. AU - Li, J. PY - 2017 DA - 2017// TI - Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells JO - Cell Death Dis VL - 8 ID - Zhao2017 ER - TY - JOUR AU - Shoemaker, A. R. AU - Mitten, M. J. AU - Adickes, J. PY - 2008 DA - 2008// TI - Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models JO - Clin Cancer Res VL - 14 ID - Shoemaker2008 ER - TY - JOUR AU - Delft, M. F. AU - Wei, A. H. AU - Mason, K. D. PY - 2006 DA - 2006// TI - The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if mcl-1 is neutralized JO - Cancer Cell VL - 10 ID - Delft2006 ER - TY - JOUR AU - Akgul, C. PY - 2009 DA - 2009// TI - Mcl-1 is a potential therapeutic target in multiple types of cancer JO - Cell Mol Life Sci VL - 66 ID - Akgul2009 ER - TY - JOUR AU - Quinn, B. A. AU - Dash, R. AU - Azab, B. PY - 2011 DA - 2011// TI - Targeting mcl-1 for the therapy of cancer JO - Expert Opin Investig Drugs VL - 20 ID - Quinn2011 ER - TY - JOUR AU - Souers, A. J. AU - Leverson, J. D. AU - Boghaert, E. R. PY - 2013 DA - 2013// TI - ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets JO - Nat Med VL - 19 ID - Souers2013 ER - TY - JOUR AU - Lamoral-Theys, D. AU - Decaestecker, C. AU - Mathieu, V. PY - 2010 DA - 2010// TI - Lycorine and its derivatives for anticancer drug design JO - Mini-Rev Med Chem VL - 10 ID - Lamoral-Theys2010 ER - TY - JOUR AU - Cedron, J. C. AU - Gutierrez, D. AU - Flores, N. AU - Ravelo, A. G. AU - Estevez-Braun, A. PY - 2010 DA - 2010// TI - Synthesis and antiplasmodial activity of lycorine derivatives JO - Bioorg Med Chem VL - 18 ID - Cedron2010 ER - TY - JOUR AU - Nair, J. J. AU - Staden, J. PY - 2012 DA - 2012// TI - Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids JO - Nat Prod Commun VL - 7 ID - Nair2012 ER - TY - JOUR AU - Cao, Z. AU - Yu, D. AU - Fu, S. PY - 2013 DA - 2013// TI - Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity JO - Toxicol Lett VL - 218 ID - Cao2013 ER - TY - JOUR AU - Zhang, K. AU - Fu, G. AU - Pan, G. PY - 2018 DA - 2018// TI - Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis JO - Cell Death Dis VL - 9 ID - Zhang2018 ER - TY - JOUR AU - Zhao, Y. AU - He, J. AU - Li, Y. AU - Lv, S. AU - Cui, H. PY - 2020 DA - 2020// TI - NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR JO - Signal Transduct Target Ther VL - 5 ID - Zhao2020 ER - TY - JOUR AU - Cao, J. AU - Zhao, E. AU - Zhu, Q. PY - 2019 DA - 2019// TI - Tubeimoside-1 inhibits Glioblastoma growth, migration, and invasion via inducing Ubiquitylation of MET JO - Cells-Basel VL - 8 ID - Cao2019 ER - TY - JOUR AU - Zhang, G. AU - Zhu, Q. AU - Fu, G. PY - 2019 DA - 2019// TI - TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis JO - Br J Cancer VL - 121 ID - Zhang2019 ER - TY - JOUR AU - Jin, Z. J. PY - 1980 DA - 1980// TI - Addition in drug combination JO - Acta Pharmacol Sin VL - 1 ID - Jin1980 ER - TY - JOUR AU - Likui, W. AU - Qun, L. AU - Wanqing, Z. PY - 2009 DA - 2009// TI - Prognostic role of myeloid cell leukemia-1 protein (mcl-1) expression in human gastric cancer JO - J Surg Oncol VL - 100 ID - Likui2009 ER - TY - JOUR AU - Ramsey, H. E. AU - Fischer, M. A. AU - Lee, T. PY - 2018 DA - 2018// TI - A novel MCL1 inhibitor combined with Venetoclax rescues Venetoclax-resistant acute Myelogenous leukemia JO - Cancer Discov VL - 8 ID - Ramsey2018 ER - TY - JOUR AU - Ferlay, J. AU - Soerjomataram, I. AU - Dikshit, R. PY - 2015 DA - 2015// TI - Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 JO - Int J Cancer VL - 136 ID - Ferlay2015 ER - TY - JOUR AU - Sieghart, W. AU - Losert, D. AU - Strommer, S. PY - 2006 DA - 2006// TI - Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy JO - J Hepatol VL - 44 ID - Sieghart2006 ER - TY - JOUR AU - Bierbrauer, A. AU - Jacob, M. AU - Vogler, M. AU - Fulda, S. PY - 2020 DA - 2020// TI - A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma JO - Br J Cancer VL - 122 ID - Bierbrauer2020 ER - TY - JOUR AU - Maurer, U. AU - Charvet, C. AU - Wagman, A. S. AU - Dejardin, E. AU - Green, D. R. PY - 2006 DA - 2006// TI - Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1 JO - Mol Cell VL - 21 ID - Maurer2006 ER - TY - JOUR AU - Tong, J. AU - Wang, P. AU - Tan, S. PY - 2017 DA - 2017// TI - Mcl-1 degradation is required for targeted therapeutics to eradicate Colon Cancer cells JO - Cancer Res VL - 77 ID - Tong2017 ER - TY - JOUR AU - Zhong, Q. AU - Gao, W. AU - Du, F. AU - Wang, X. PY - 2005 DA - 2005// TI - Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of mcl-1 and regulates apoptosis JO - CELL VL - 121 ID - Zhong2005 ER - TY - JOUR AU - Ding, Q. AU - He, X. AU - Hsu, J. M. PY - 2007 DA - 2007// TI - Degradation of mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization JO - Mol Cell Biol VL - 27 ID - Ding2007 ER - TY - JOUR AU - Inuzuka, H. AU - Shaik, S. AU - Onoyama, I. PY - 2011 DA - 2011// TI - SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction JO - NATURE VL - 471 ID - Inuzuka2011 ER - TY - JOUR AU - Wertz, I. E. AU - Kusam, S. AU - Lam, C. PY - 2011 DA - 2011// TI - Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 JO - Nature VL - 471 ID - Wertz2011 ER - TY - JOUR AU - Wu, X. AU - Luo, Q. AU - Zhao, P. PY - 2020 DA - 2020// TI - JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1 JO - Cell Death Differ VL - 27 ID - Wu2020 ER - TY - JOUR AU - Wu, X. AU - Luo, Q. AU - Zhao, P. PY - 2019 DA - 2019// TI - MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer JO - Proc Natl Acad Sci U S A VL - 116 ID - Wu2019 ER - TY - JOUR AU - Zhang, S. AU - Zhang, M. AU - Jing, Y. PY - 2018 DA - 2018// TI - Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors JO - Nat Commun VL - 9 ID - Zhang2018 ER - TY - JOUR AU - Schwickart, M. AU - Huang, X. AU - Lill, J. R. PY - 2010 DA - 2010// TI - Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival JO - Nature VL - 463 ID - Schwickart2010 ER - TY - JOUR AU - Wei, S. H. AU - Dong, K. AU - Lin, F. PY - 2008 DA - 2008// TI - Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting mcl-1 gene in pancreatic carcinoma cell JO - Cancer Chemother Pharmacol VL - 62 ID - Wei2008 ER - TY - JOUR AU - Xia, X. AU - Huang, C. AU - Liao, Y. PY - 2019 DA - 2019// TI - Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide JO - J Exp Clin Cancer Res VL - 38 ID - Xia2019 ER -